Recent Pathophysiological Aspects of Peyronie’s Disease: Role of Free Radicals, Rationale, and Therapeutic Implications for Antioxidant Treatment—Literature Review

作者: Gianni Paulis , Gennaro Romano , Luca Paulis , Davide Barletta

DOI: 10.1155/2017/4653512

关键词: InflammationAntioxidants TherapyDiseaseTamoxifenMedicineImmunologyOxidative stressProinflammatory cytokinePeyronie's diseasePathogenesisBioinformatics

摘要: Peyronie’s disease (PD) is a chronic inflammation of tunica albuginea the corpora cavernosa that causes an inelastic plaque resulting in penis deformation. Although its etiology not completely known, there general consensus PD genetically transmitted and secondary to penile trauma. In recent years, numerous studies demonstrated role played by oxidative stress pathogenesis, other have described successful use antioxidants treatment. Oxidative integral part this disease, influencing progression. early stages PD, inflammatory infiltrate cells produce high quantities free radicals proinflammatory profibrotic cytokines, with consequent activation transcription factor NF-κB. While conservative therapies commonly used include oral substances (Potaba, tamoxifen, colchicine, vitamin E), intralesional treatment (verapamil, interferon, steroids, more recently collagenase clostridium histolyticum-Xiaflex), local physical (iontophoresis, extracorporeal shock wave therapy, extender), significant results obtained emerging treatments cited article suggest these therapeutic agents interfere at several levels disease’s pathogenetic mechanisms. Antioxidants therapy outcomes are interesting for good clinical practice also confirm fundamental PD.

参考文章(139)
Elizabeth Gonzalez Oramas, Rafaela Bordonado Ramirez, Manuel Lemourt Oliva, Félix Molina Castillo, Ada Rodriguez Barroso, Estudio de dosis con Propóleo en la enfermedad de Peyronie. Archivos españoles de urología. ,vol. 56, pp. 814- 819 ,(2003)
Mahmoud Lotfy Khalil, Biological activity of bee propolis in health and disease. Asian Pacific Journal of Cancer Prevention. ,vol. 7, pp. 22- 31 ,(2006)
Magdelin Navarro Cutino, Antonio Perez Monzon, Manuel Lemourt Oliva, Concepcion Vega Guerrero, Marta Puente Guillen, Ada Rodriguez Barroso, Propóleo y Enfermedad de Peyronie. Archivos españoles de urología. ,vol. 56, pp. 805- 813 ,(2003)
Lu-ting Zhou, Ke-jia Wang, Ling Li, Hui Li, Ming Geng, Pinocembrin inhibits lipopolysaccharide-induced inflammatory mediators production in BV2 microglial cells through suppression of PI3K/Akt/NF-κB pathway. European Journal of Pharmacology. ,vol. 761, pp. 211- 216 ,(2015) , 10.1016/J.EJPHAR.2015.06.003
Giuseppe La Pera, Franco Di Silverio, Susanna Scarpa, Fortunata Vasaturo, Andrea Modesti, Andrea Modesti, Alessandro Modica, Vincenzo Gentile, Gianrico Prigiotti, Ultrastructural and immunohistochemical characterization of the tunica albuginea in Peyronie's disease and veno-occlusive dysfunction Journal of Andrology. ,vol. 17, pp. 96- 103 ,(1996) , 10.1002/J.1939-4640.1996.TB01757.X
G. Paulis, R. D’Ascenzo, P. Nupieri, G. De Giorgio, G. Orsolini, T. Brancato, R. Alvaro, Effectiveness of antioxidants (propolis, blueberry, vitamin E) associated with verapamil in the medical management of Peyronie's disease: a study of 151 cases. International Journal of Andrology. ,vol. 35, pp. 521- 527 ,(2012) , 10.1111/J.1365-2605.2011.01219.X
Raffaele Landolfi, Richard L. Mower, Manfred Steiner, Modification of platelet function and arachidonic acid metabolism by bioflavonoids: Structure-activity relations Biochemical Pharmacology. ,vol. 33, pp. 1525- 1530 ,(1984) , 10.1016/0006-2952(84)90423-4
Halal Aa, Geavlete P, Ceban E, Pharmacological therapy in patients diagnosed with Peyronie's disease Journal of medicine and life. ,vol. 5, pp. 192- 195 ,(2012)
Michael R. Abern, Stephen Larsen, Laurence A. Levine, Combination of Penile Traction, Intralesional Verapamil, and Oral Therapies for Peyronie's Disease The Journal of Sexual Medicine. ,vol. 9, pp. 288- 295 ,(2012) , 10.1111/J.1743-6109.2011.02519.X